GRHL2 and metastatic malignant neoplasm: GRHL2 upregulation in the CTC lines prompted us to study its expression in more detail using microarray data (GEO accession number GSE41258) of primary colon adenocarcinoma, metastatic cancer, and the corresponding normal mucosa samples.